This study aims to investigate the association between blood levels of lead and cadmium and subclinical cardiovascular disease, as evidenced by elevated hs-cTnT and NT-proBNP, in a diverse cohort of U.S. adults. This evidence concerns the gene TNNT2 and cardiovascular disorder.